Mri s/o hyperintentensity in bl temporal and cerebellar lobe with 2 Yr History of progressive cerebellar sym diagnosis
bilateral temporal cerebellar hyperintensity MRI progressive ataxia diagnosis
autoimmune cerebellar ataxia temporal lobe encephalitis MRI T2 hyperintensity
progressive cerebellar ataxia temporal lobe T2 hyperintensity differential diagnosis
autoimmune cerebellar ataxia antibody mediated treatment review
immune-mediated cerebellar ataxia diagnosis antibodies MRI findings
bilateral temporal cerebellar T2 FLAIR hyperintensity progressive ataxia 2 years differential diagnosis MRI
| Feature | Detail |
|---|---|
| Pathology | Autoantibodies against neural surface or intracellular antigens |
| MRI | Bilateral mesial temporal T2/FLAIR hyperintensity (limbic) + cerebellar changes |
| Course | Can be subacute to chronic progressive over monthsβyears |
| Key antibodies | Anti-Hu (ANNA-1), Anti-Yo (PCA-1), Anti-Ri, anti-VGCC, anti-CASPR2, anti-LGI1, anti-NMDAR, anti-GAD65 |
| Feature | Detail |
|---|---|
| Classic MRI | Bilateral medial temporal lobe T2/FLAIR hyperintensity β hallmark finding |
| Antibodies | Anti-LGI1, anti-CASPR2, anti-NMDAR, anti-AMPAR, anti-GABA-B |
| Cerebellar involvement | Anti-GABA-B and anti-CASPR2 subtypes especially can extend to cerebellum |
| Associated | Seizures, amnesia, psychiatric symptoms, confusion |
| Feature | Detail |
|---|---|
| MELAS | Stroke-like episodes, bilateral cortical/temporal signal changes |
| POLG | Progressive ataxia, COX-deficient fibers on muscle biopsy, cerebellar involvement |
| Maternal inheritance / de novo | |
| MRI | Asymmetric cortical/subcortical, temporal > occipital in MELAS; cerebellar atrophy in POLG |
STEP 1 β MRI Review
βββ Confirm: Bilateral medial temporal T2/FLAIR hyperintensity?
βββ Cerebellar: atrophy, white matter signal, MCP sign?
βββ DWI: restricted diffusion? (CJD, stroke)
βββ Enhancement pattern: perivascular (CLIPPERS), nodular, leptomeningeal?
βββ Temporal pole involvement (CADASIL)?
STEP 2 β Blood Tests
βββ Paraneoplastic panel: Anti-Hu, Anti-Yo, Anti-Ri, Anti-CV2, Anti-Ma2, Anti-VGCC
βββ Autoimmune encephalitis: Anti-LGI1, Anti-CASPR2, Anti-NMDAR, Anti-GABA-B
βββ Anti-GAD65 (high titre)
βββ Thyroid antibodies (anti-TPO, anti-TG) β Hashimoto encephalopathy
βββ Anti-gliadin, anti-TG6, anti-tTG β Gluten ataxia / celiac
βββ ANA, dsDNA, ANCA, ACE β Lupus, vasculitis, sarcoidosis
βββ Mitochondrial: lactate, pyruvate, genetic testing (POLG, MTTL1)
βββ FMR1 premutation screen (males, family history)
βββ HIV, RPR/VDRL, Lyme serology
STEP 3 β CSF Analysis
βββ Cell count, protein, glucose, IgG index, oligoclonal bands
βββ Paraneoplastic + autoimmune antibody panel (CSF more sensitive for some)
βββ 14-3-3 protein, total tau, RT-QuIC (if CJD suspected)
βββ Culture, PCR (HSV, EBV, JCV, VZV, CMV)
βββ Cytology + flow cytometry (CNS lymphoma)
STEP 4 β Oncology Screening
βββ CT chest/abdomen/pelvis (lung, ovarian, breast cancer)
βββ PET-CT if CT negative and paraneoplastic suspected
βββ Testicular ultrasound in young males
STEP 5 β Tissue / Special
βββ Muscle biopsy with COX/SDH stain if mitochondrial suspected
βββ Skin biopsy for CADASIL (NOTCH3 electron microscopy)
βββ Brain biopsy if all else negative and steroid trial fails
Beaver sign and causes and dd
Beaver sign neurology clinical sign causes differential diagnosis
"Beaver sign" neurology neck flexion weakness
"Beevor sign" facioscapulohumeral dystrophy spinal cord
Beevor sign causes differential diagnosis anatomy pathophysiology
Note: The correct spelling is Beevor's sign (named after British neurologist Charles Edward Beevor, 1854β1908). "Beaver sign" is a common phonetic misspelling in clinical settings.
| Segment | Innervates |
|---|---|
| T7βT9 | Upper rectus abdominis |
| T10βT12 | Lower rectus abdominis |
| Observation | Interpretation |
|---|---|
| Umbilicus moves up >1 cm | Positive Beevor's sign β lower abdominal weakness (T10βT12) |
| Umbilicus remains stationary | Negative (normal) |
| Umbilicus moves down >1 cm | Inverted Beevor's sign β upper abdominal weakness (T7βT9) |
| Umbilicus shifts laterally | Extended Beevor's sign β asymmetric paraspinal/rectus atrophy (one side) |
| Condition | Notes |
|---|---|
| Spinal cord tumor (T10βT12) | First described by Beevor in a patient with T11βT12 tumor |
| Spinal cord trauma / transection | Cord injury at T9βT10 level |
| Spinal cord infarction | Acute presentation; vascular lesion below T10 |
| Transverse myelitis | Inflammatory/demyelinating at thoracic level |
| Multiple sclerosis | Demyelinating plaques at T9βT12 |
| Epidural abscess/hematoma | Compressive cord lesion |
| HTLV-1 myelopathy | Tropical spastic paraparesis |
| Condition | Mechanism |
|---|---|
| Diabetic truncal neuropathy | Segmental thoracic root involvement at T10βT12 |
| Thoracic radiculopathy | Infiltrative (metastatic), inflammatory, or compressive |
| Post-herpetic thoracic mononeuropathy | Segmental T10βT12 injury |
| Feature | Spinal Cord Lesion | FSHD |
|---|---|---|
| Onset | Acute or subacute | Insidious, decades |
| Sensory level | Present (T9βT10) | Absent |
| Paraplegia / UMN signs | Present | Absent |
| Facial weakness | Absent | Present (orbicularis) |
| Scapular winging | Absent | Classic feature |
| Family history | Absent | AD inheritance (4q35 deletion) |
| CK | Normal | Mildlyβmoderately elevated |
| EMG | Neurogenic | Myopathic |
| MRI spine | Cord lesion visible | Normal |
Border zone infarct watershed territory and clinical presentation with ocular manifestations and causes